8 employees
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.
2020
GelMEDIX raised undisclosed on March 10, 2022
Investors: Safar Partners and HTL Biotechnology
GelMEDIX raised undisclosed on June 4, 2020
Investors: EQx Fund and Safar Partners